Apr 16 |
As more rare disease therapies launch, their prices are rising
|
Apr 14 |
10 Unstoppable Stocks That Will Make You Richer
|
Apr 11 |
Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy
|
Apr 8 |
Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts
|
Apr 8 |
Why Sarepta's First-Quarter Report Is Already Dead In The Water: Analyst
|
Apr 6 |
2 Biotech Stocks to Buy Hand Over Fist in April
|
Apr 2 |
Outperforming ETF manager names a potential ‘50-bagger’ in the stock market
|
Mar 29 |
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
|
Mar 29 |
Sarepta Therapeutics' (NASDAQ:SRPT) growing losses don't faze investors as the stock increases 3.6% this past week
|
Mar 25 |
A Comprehensive Look at Sarepta's Growth and Innovation
|